BioSpace News Archive

Generate:Biomedicines today announced a publication in Nature describing Chroma, a generative AI model that can program novel proteins not previously found in nature with targeted biophysical, biological, and therapeutic properties.

KDx Diagnostics inc. is announcing the partnership with leading distributors in the Middle East & Europe serves as a testament to KDx Diagnostics’ dedication to expanding its global presence.

Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in a fireside discussion and one-on-one meetings at the Piper Sandler Healthcare Conference being held November 28-30, 2023 in New York City.

Agilent Technologies Inc. announced the company has increased its quarterly dividend to 23.6 cents per share of common stock, a 5% increase over the previous dividend.

Reverb Therapeutics Debuts Its Amplifier ™ Platform for Redirecting Endogenous Cytokines.

AtriCure, Inc. today announced that the company will be participating in the upcoming Piper Sandler 35th Annual Healthcare Conference.

AltPep Corporation announced the appointment of Steven E. Kahn, M.B., Ch.B. to its Advisory Board.

Carmot Therapeutics Inc. today announced that it has commenced a Phase 2 clinical trial of its once-daily dual GLP-1/GIP receptor agonist, CT-868, in adult participants with overweight or obesity with T1D.

Cyclo Therapeutics, Inc. today reported its financial results for the third quarter 2023.

Nanalysis Scientific Corp. announces that on Wednesday, November 29th, 2023, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending September 30, 2023.